References
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29.
- Pennathur A, Gibson MK, Jobe BA, et al. Oesophagealcarcinoma. Lancet. 2013;381:400–12.
- Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–53.
- Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018. CA Cancer J Clin. 2018;68(6):394–424.
- Zhang Y. Epidemiology of esophageal cancer. World J Gastroenterol. 2013;19:5598–606.
- Zhang L, Du C, Guo X, et al. Interleukin-8-251A/T polymorphism and Helicobacter pylori infection influence risk for the development of gastric cardiac adenocarcinoma in a high-incidence area of China. Mol Biol Rep. 2010;37:3983–9.
- Crew KD, Neugut AI. Epidemiology of upper gastrointestinal malignancies. Semin Oncol. 2004;31:450–64.
- Hiyama T, Yoshihara M, Tanaka S, et al. Genetic polymorphisms and esophageal cancer risk. Int J Cancer. 2007;121:1643–58.
- Kamangar F, Chow WH, Abnet CC, et al. Environmental causes of esophageal cancer. Gastroenterol Clin North Am. 2009;38:27–57.
- Fan Y, Yuan JM, Wang R, Gao Y-T, Yu MC. Alcohol, tobacco, and diet in relation to esophageal cancer: the Shanghai Cohort Study. Nutr Cancer. 2008;60:354–63.
- Tran GD, Sun XD, Abnet CC, et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer. 2005;113:456–63.
- Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol. 2003;56:1–9.
- Gammon MD, Schoenberg JB, Ahsan H, et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1997;89:1277–84.
- Zhang W, Li C, Wang J, et al. Functional polymorphisms in FAS/FASL system contribute to the risk of occurrence but not progression of gastric cardiac adenocarcinoma. Hepato-gastroenterology. 2012;59:141–6.
- Stemmler MP, Bedzhov I. A Cdh1HA knock-in allele rescues the Cdh1-/- phenotype but shows essential Cdh1 function during placentation. Dev Dyn. 2010;239:2330–44.
- Chen B, Zhou Y, Yang P, et al. CDH1-160C > A polymorphism is anethnicity-dependent risk factor for gastric cancer. Cytokine. 2011;55:266–73.
- Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991;251:1451–5.
- Margineanu E, Cotrutz CE, Cotrutz C. Correlation between E-cadherinabnormal expressions in different types of cancer and the process of metastasis. Rev Med ChirSoc Med Nat Iasi. 2008;112:432–6.
- Paul R, Ewing CM, Jarrard DF, et al. The cadherin cell-cell adhesionpathway in prostate cancer progression. Br J Urol. 1997;79:37–43.
- Reinhold WC, Reimers MA, Lorenzi P, et al. Multifactorial regulation of E-cadherin expression: an integrative study. Mol Cancer Ther. 2010;9:1–16.
- Shin Y, Kim IJ, Kang HC, et al. The E-cadherin-347G->GA promoter polymorphism and its effect on transcriptional regulation. Carcinogenesis. 2004;25:895–9.
- Li LC, Chui RM, Sasaki M, et al. A singlenucleotide polymorphism in the E-cadherin gene promoter alters transcriptionalactivities. Cancer Res. 2002;60:873–6.
- Miller SA, Dybes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res. 1988;16(3):1215–7.
- Plotkin JB, Kudla G. Synonymous but not the same: the causes and consequences of codon bias. Nat Rev Genet. 2011;12:32–42.
- Hunt RC, Simhadri VL, Iandoli M, et al. Exposing synonymous mutations. Trends Genet. 2014;30:308–21.
- Bali V, Bebok Z. Decoding mechanisms by which silent codon changes influence protein biogenesis and function. Int J Biochem Cell Biol. 2015;64:58–74.
- Chamary JV, Parmley JL, Hurst LD. Hearing silence: non-neutralevolution at synonymous sites in mammals. Nat Rev Genet. 2006;7:98–108.
- Quax TE, Claassens NJ, Soll D, et al. Codon Bias as a Means to Fine-Tune Gene Expression. Mol Cell. 2015;59(2):149–61.
- Hershberg R, Petrov D. Selection on codon bias. Annu Rev Genet. 2008;42:287–99.
- Gu W, Gurguis CI, Zhou JJ, et al. Functional and structural consequence of rare Exonic single nucleotide polymorphisms: one story, two Tales. Genome Biol Evol. 2015;7:2929–40.
- Thomas E, Gorochowski , ZoyaIgnatova , et al. Trade-offs between tRNA abundance and mRNA secondary structure support smoothing of translation elongation rate. Nucleic Acids Res. 2015;43(6):3022–32.
- Kramer EB, Farabaugh PJ. The frequency of translational misreading errors in E. coli is largely determined by tRNA competition. RNA. 2007;13:87–96.
- Gingold H, Pilpel Y. Determinants of translation efficiency and accuracy. Mol Syst Biol. 2011;7:481.
- Supek F, Miana B, Valcrcel J, et al. Synonymous mutations frequently act as driver mutations in human cancers. Cell. 2014;156(6):1324–35.
- Caggiari L, Miolo G, Buonaclonna A, et al. Characterizing metastatic HER2-positive gastric cancer at the CDH1 haplotype. Int J Mol Sci. 2018;19(47):110–26.
- Zhan Z, Wu J, Zhang JF, et al. CDH1 gene polymorphisms, plasma CDH1 levels and risk of gastric cancer in a Chinese population. Mol Biol Rep. 2012;39:8107–13.